Evaluation of transgene expression characteristics and DNA vaccination against melanoma metastasis of an intravenously injected ternary complex with biodegradable dendrigraft poly-L-lysine in mice
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 28 (1) , 542-549
Abstract
We developed a biocompatible splenic vector for a DNA vaccine against melanoma. The splenic vector is a ternary complex composed of plasmid DNA (pDNA), biodegradable dendrigraft poly-L-lysine (DGL), and γ-polyglutamic acid (γ-PGA), the selective uptake of which by the spleen has already been demonstrated. The ternary complex containing pDNA encoding luciferase (pCMV-Luc) exhibited stronger luciferase activity for RAW264.7 mouse macrophage-like cells than naked pCMV-Luc. Although the ternary complex exhibited strong luciferase activity in the spleen after its tail vein injection, luciferase activity in the liver and spleen was significantly decreased by a pretreatment with clodronate liposomes, which depleted macrophages in the liver and spleen. These results indicate that the ternary complex is mainly transfected in macrophages and is a suitable formulation for DNA vaccination. We applied the ternary complex to a pUb-M melanoma DNA vaccine. The ternary complex containing pUb-M suppressed the growth of melanoma and lung metastasis by B16-F10 mouse melanoma cells. We also examined the acute and liver toxicities of the pUb-M ternary complex at an excess pDNA dose in mice. All mice survived the injection of the excess amount of the ternary complex. Liver toxicity was negligible in mice injected with the excess amount of the ternary complex. In conclusion, we herein confirmed that the ternary complex was mainly transfected into macrophages in the spleen after its tail vein injection. We also showed the prevention of melanoma metastasis by the DNA vaccine and the safety of the ternary complex.Keywords
Funding Information
- Japan Society for the Promotion of Science (JSPS) Kakenhi (18H02589)
This publication has 32 references indexed in Scilit:
- FDA guidance on prophylactic DNA vaccines: Analysis and recommendationsVaccine, 2010
- Ternary complexes of pDNA, polyethylenimine, and γ-polyglutamic acid for gene delivery systemsBiomaterials, 2009
- Inhibition of adhesion and proliferation of peritoneally disseminated tumor cells by pegylated catalaseClinical & Experimental Metastasis, 2006
- Toxicity of cationic lipids and cationic polymers in gene deliveryJournal of Controlled Release, 2006
- Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on StageClinical Cancer Research, 2006
- Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasisThe Journal of Pathology, 2006
- Vaccines: past, present and futureNature Medicine, 2005
- Inhibition of Metastatic Tumor Growth in Mouse Lung by Repeated Administration of Polyethylene Glycol-Conjugated CatalaseClinical Cancer Research, 2004
- Side‐effects of a systemic injection of linear polyethylenimine–DNA complexesThe Journal of Gene Medicine, 2001
- Inhibition of Experimental Lung Metastasis by Aerosol Delivery of PEI–p53 ComplexesMolecular Therapy, 2000